Description
ALUNBRIG® 30 mg es un medicamento oncológico de Takeda Pharmaceuticals que contiene brigatinib como principio activo
Seguir estrictamente las instrucciones del fabricante
Rotar los sitios de aplicación
PRINCIPIO ACTIVO: IRBESARTAN HIRDORCLOROTIAZIDA 300 MG
Crema auxiliar en el tratamiento
CAPTRAL 25 MG TAB 30 1+1 SALMETEROL-FLUTICASONA ALUNBRIG® 30 mg es unPRINCIPIO ACTIVO: CAPTOPRIL DOSIS: 25 MG FORMA FARMACUTICA: 30 TABLETAS PRESENTACIN: 1 CAJA
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
recommand products
